Featured Firms
Presented by BigVoodoo
In the litigation over alleged illegal pricing tactics used in marketing the prostate cancer drug Lupron, the fate of hundreds of plaintiffs remains unclear despite a federal judge's approval earlier this month of $150 million in settlements. And complicating the claims of nearly all of the so-called "opt-out" plaintiffs is the fact that their lawyers were harshly criticized by the judge for their marketing tactics, which included a pair of Web sites and an allegedly misleading "Dear Client" letter.
May 25, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS